BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Santana AL, Felsen D, Carucci JA. Interleukin-22 and Cyclosporine in Aggressive Cutaneous Squamous Cell Carcinoma. Dermatol Clin. 2017;35:73-84. [PMID: 27890239 DOI: 10.1016/j.det.2016.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Becker JC, Stang A, DeCaprio JA, Cerroni L, Lebbé C, Veness M, Nghiem P. Merkel cell carcinoma. Nat Rev Dis Primers 2017;3:17077. [PMID: 29072302 DOI: 10.1038/nrdp.2017.77] [Cited by in Crossref: 181] [Cited by in F6Publishing: 151] [Article Influence: 36.2] [Reference Citation Analysis]
2 Hart PH, Norval M. Ultraviolet radiation-induced immunosuppression and its relevance for skin carcinogenesis. Photochem Photobiol Sci 2018;17:1872-84. [PMID: 29136080 DOI: 10.1039/c7pp00312a] [Cited by in Crossref: 40] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
3 Wu Q, Wang X, Nepovimova E, Wang Y, Yang H, Kuca K. Mechanism of cyclosporine A nephrotoxicity: Oxidative stress, autophagy, and signalings. Food and Chemical Toxicology 2018;118:889-907. [DOI: 10.1016/j.fct.2018.06.054] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 9.8] [Reference Citation Analysis]
4 Huang W, Lu W, Li Q, Zhang Y, Xie B, Luo S, Wei Y, Ma Y, Huang Y. Effects of cyclosporine A on proliferation, invasion and migration of HTR-8/SVneo human extravillous trophoblasts. Biochem Biophys Res Commun 2020;533:645-50. [PMID: 33032826 DOI: 10.1016/j.bbrc.2020.09.072] [Reference Citation Analysis]
5 Jalalat S, Agoris C, Fenske NA, Cherpelis B. Management of Non-melanoma Skin Cancers: Basal Cell Carcinoma, Squamous Cell Carcinoma. In: Riker AI, editor. Melanoma. Cham: Springer International Publishing; 2018. pp. 591-604. [DOI: 10.1007/978-3-319-78310-9_37] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Belitskiy GA, Kirsanov KI, Lesovaya EA, Yakubovskaya MG. Drug-Related Carcinogenesis: Risk Factors and Approaches for Its Prevention. Biochemistry (Mosc) 2020;85:S79-S107. [PMID: 32087055 DOI: 10.1134/S0006297920140059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
7 Feldman SR, Lacy FA, Huang WW. The safety of treatments used in pyoderma gangrenosum. Expert Opinion on Drug Safety 2018;17:55-61. [DOI: 10.1080/14740338.2018.1396316] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
8 Georgescu SR, Tampa M, Mitran CI, Mitran MI, Caruntu C, Caruntu A, Lupu M, Matei C, Constantin C, Neagu M. Tumour Microenvironment in Skin Carcinogenesis. Adv Exp Med Biol 2020;1226:123-42. [PMID: 32030681 DOI: 10.1007/978-3-030-36214-0_10] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
9 Manzia TM, Angelico R, Gazia C, Lenci I, Milana M, Ademoyero OT, Pedini D, Toti L, Spada M, Tisone G, Baiocchi L. De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature. World J Gastroenterol 2019; 25(35): 5356-5375 [PMID: 31558879 DOI: 10.3748/wjg.v25.i35.5356] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
10 Burra P, Shalaby S, Zanetto A. Long-term care of transplant recipients: De novo neoplasms after liver transplantation. Curr Opin Organ Transplant. 2018;23:187-195. [PMID: 29324517 DOI: 10.1097/mot.0000000000000499] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 4.3] [Reference Citation Analysis]
11 Choudhary NS, Saigal S, Saraf N, Soin AS. Extrahepatic Malignancies and Liver Transplantation: Current Status. J Clin Exp Hepatol 2021;11:494-500. [PMID: 34276155 DOI: 10.1016/j.jceh.2020.10.008] [Reference Citation Analysis]
12 Abikhair Burgo M, Roudiani N, Chen J, Santana AL, Doudican N, Proby C, Felsen D, Carucci JA. Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma. JCI Insight 2018;3:120750. [PMID: 30185657 DOI: 10.1172/jci.insight.120750] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]